Yeung et al. [94] reported that serum levels of FABP4 had a significantly inverse relationship with the estimated GFR (eGFR) and was independently associated with macrovascular complications and DN staging classified by albuminuria. The gene discussed is FABP4; the disease is liver dysplastic nodule.